Posts
September 29 2014
Lpath, Inc. announced the closing of its previously announced $12.5 million registered direct offering. Lpath sold registered shares of common stock and warrants to purchase unregistered shares of common stock in a registered direct offering. EG&S acted as counsel to the placement agent.
September 24 2014
Baxano Surgical, Inc. announced the closing of their Registered Direct offering in the amount of $1,384,801. EG&S acted as counsel to the Investor.
September 23 2014
Advanced Plasma Therapies, Inc., a privately held, development-stage biotechnology company, closed a private common stock financing of $25 million with a single institutional investor. EG&S acted as counsel to Advanced Plasma Therapies.
September 23 2014
LabStyle Innovations Corp. (OTCQB:DRIO) announced the closing of a $4.2 million private placement consisting of preferred stock and warrants. EG&S acted as counsel to LabStyle.
September 22 2014
Hennessy Capital Acquisition Corp. announced the agreement to acquire Blue Bird. EG&S acted as co-counsel to Hennessy with Sidley Austin LLP.
September 11 2014
Douglas S. Ellenoff, a member of the Firm, will receive the “Crowdfunding Visionary Award” at the 3rd Annual Global Crowdfunding Convention and Bootcamp this October in Las Vegas.
September 11 2014
Client Alert: Issuers and Corporate Insiders Should Revisit Procedures for Reporting Ownership in View of SEC’s Announcement of Enforcement Proceedings. The alert prepared by Adrienne Ward and David Selengut, members of the Firm, discusses this new enforcement initiative and suggest best practices for issuers and corporate officers.
September 03 2014
Orient Paper Inc. announced the closing of their Registered Direct offering in the amount of $2,500,000. EG&S acted as counsel to the Placement Agent.